.jpg?width=520&name=social%20media%20805x403(7).jpg)
Calprotectin at PReS 2025: Advancing Paediatric Rheumatology Care
Learn more about circulating calprotectin at booth #4 Gentian Diagnostics is excited to join the 32nd annual..
Read more.png?width=520&name=Exhibitons%20new(1).png)
Meet GCAL® in September: Circulating calprotectin for routine rheumatology
Learn how circulating calprotectin supports better patient care in IRDs Meet us at three key European..
Read more.jpg?width=520&name=Exhibitions%20805x403(55).jpg)
Discover circulating calprotectin at ADLM 2025
Circulating calprotectin - Promising inflammation biomarker Calprotectin (S100A8/A9 or MRP8/14) is a..
Read more
Benefits of avian antibodies in turbidimetric immunoassays
Immunoassays, like the PETIA (Particle-Enhanced Turbidimetric Immunoassay) assays developed by Gentian, are..
Read more.jpg?width=520&name=Exhibitions-805x403(51).jpg)
Gentian showcases diagnostic research at EuroMedLab 2025
Posters: Retinol-Binding Protein and NT-proBNP At EuroMedLab 2025 in Brussels, Gentian Diagnostics will..
Read more
Canine CRP assay at EuroMedLab 2025
Learn more about Gentian's turbidimetric canine CRP assay at booth #115 Gentian Diagnostics will also this..
Read more.png?width=520&name=Exhibitions%20805x403(54).png)
Gentian @ EuroMedLab 2025: Raising the standard in inflammation testing with GCAL®
GCAL® Calprotectin – A new standard in inflammation testing At EuroMedLab 2025 in Brussels, Gentian..
Read more.png?width=520&name=Exhibitions%20805x403(51).png)
Meet the cystatin C company at EuroMedLab2025
It's time to add cystatin C to the lab menu - visit booth #115
Read more.png?width=520&name=Exhibitions%20805x403(50).png)
Retinol-Binding Protein (RBP) at #EuroMedLab2025
Interested in Retinol-Binding Protein (RBP)? The Gentian Retinol-Binding Protein immunoassay offers a..
Read more.jpg?width=520&name=social%20media%20805x403(1).jpg)
Circulating calprotectin - the power to assess inflammation
Circulating calprotectin - the power to assess inflammation Newsletter 1/2025 It’s clear that the awareness..
Read more